286 related articles for article (PubMed ID: 10049264)
21. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
[TBL] [Abstract][Full Text] [Related]
22. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
[TBL] [Abstract][Full Text] [Related]
23. Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.
Zhou M; Geng X; Chen J; Wang X; Wang D; Deng J; Zhang Z; Wang W; Zhang XE; Wei H
PLoS One; 2011; 6(11):e27654. PubMed ID: 22102918
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.
Li H; Chen J; Zhou M; Geng X; Yu J; Wang W; Zhang XE; Wei H
J Clin Microbiol; 2014 Jan; 52(1):260-7. PubMed ID: 24226918
[TBL] [Abstract][Full Text] [Related]
25. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
26. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
[TBL] [Abstract][Full Text] [Related]
27. Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3).
Purkan P; Hadi S; Retnowati W; Sumarsih S; Wahyuni DK; Piluharto B; Panjaitan TM; Ifada C; Nadila A; Nabilah BA
Braz J Biol; 2024; 84():e278911. PubMed ID: 38422295
[TBL] [Abstract][Full Text] [Related]
28. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
29. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
Doustdar F; Pazhang M; Mehrnejad F; Safarzadeh M; Rabiei D; Chaparzadeh N; Falahati H; Mir-Derikvand M
Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
[TBL] [Abstract][Full Text] [Related]
30. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
[TBL] [Abstract][Full Text] [Related]
31. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
32. Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance.
Khan MT; Malik SI
J Biomol Struct Dyn; 2020 Jul; 38(10):3003-3017. PubMed ID: 31357912
[TBL] [Abstract][Full Text] [Related]
33. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
[TBL] [Abstract][Full Text] [Related]
35. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
Suzuki Y; Suzuki A; Tamaru A; Katsukawa C; Oda H
J Clin Microbiol; 2002 Feb; 40(2):501-7. PubMed ID: 11825963
[TBL] [Abstract][Full Text] [Related]
36. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
Shi W; Zhang X; Jiang X; Yuan H; Lee JS; Barry CE; Wang H; Zhang W; Zhang Y
Science; 2011 Sep; 333(6049):1630-2. PubMed ID: 21835980
[TBL] [Abstract][Full Text] [Related]
37. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
38. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
Bamaga M; Zhang H; Wright DJ
Microb Drug Resist; 2001; 7(3):223-8. PubMed ID: 11759083
[TBL] [Abstract][Full Text] [Related]
39. Escherichia coli genes involved in resistance to pyrazinoic acid, the active component of the tuberculosis drug pyrazinamide.
Schaller A; Guo M; Gisanrin O; Zhang Y
FEMS Microbiol Lett; 2002 Jun; 211(2):265-70. PubMed ID: 12076823
[TBL] [Abstract][Full Text] [Related]
40. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
